-
Super Agers Initiative Uncovers Biological Mysteries of Longevity, MD Anderson’s Novel Small-Molecule Oncology Therapies Research, More
Nov 30 | Clinical Research News | A newly developed immunotherapy drug that delays the onset of type 1 diabetes in at-risk individuals by an average of almost three years; a study to engineer a human heart model, elucidate fundamental laws of muscular pumps, and apply lessons learned to a cardiovascular bio digital twin model; a highly flexible, modular patent-pending platform and wearable sensor designed to meet the specific needs of clinical trials and remote patient research; and more. More -
Follow the Money: Global Digital Therapeutics Clinical Research, Targeted and Minimally Invasive Anti-Cancer Research Platform, More
Nov 29 | Clinical Research News | Funding for clinical-stage urologic oncology pipeline, novel brain cancer research platform, immune microenvironment research of triple-negative breast cancer, and more. More -
Pistoia Alliance Works to Mine RWD From Social Media
Nov 22 | Clinical Research News | The Pistoia Alliance has launched a new Community of Experts (CoE) to harness real-world data from social media. The CoE aims to develop best practices and guidelines to use social media analysis as real-world data for patient-focused drug development. More -
Vivli To Expand Due To New Data-Sharing Policy Affecting NIH-Funded Research
Nov 16 | Clinical Research News | There is little doubt about the “data magnetism” of Vivli, an open-access, data-sharing platform integrating clinical trial data contributed by biopharmaceutical sponsors, academic institutions, and nonprofit foundations around the world. Vivli was created as a generalist repository in 2018 and since then has driven 126 new research findings—all publicly disclosed, primarily in the peer-reviewed literature. More -
Social Determinants Of Health Data Help Identify Sites For Trials
Nov 15 | Clinical Research News | The movement toward decentralized clinical trials isn’t the only emerging trend that could help bump up clinical trial diversity. So, too, could the use of social determinants of health insights to better choose the sites and investigators most likely to enroll underrepresented individuals. More
The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.
